To our knowledge, except for the increased dosing effect of RUNX1 in ML-DS, no increased prevalence and no specific mechanism of interaction between altered RUNX1 and GATA1 has been described [31, 43–45]. The gene discussed is GATA1; the disease is Dravet syndrome.